Adherence of Hispanic / Latina Breast Cancer - Patients to Adjuvant Aromatase Inhibitors (ALPA)

Texas Tech University Health Sciences Center, El Paso

Status: Completed

Conditions: Breast Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT03144037

E17086

Details and patient eligibility

About

This is an observational trial designed to assess prospectively the adherence rate to AIs among women with invasive breast cancer (stages I-III) currently receiving AI adjuvant therapy after standard local and systemic therapy. We will study adherence by administrating the 8-item Morisky Medication Adherence Scale (MMAS - 8).

Full description

• Women with breast cancer seen at the Texas Tech Physicians Breast Care Center will be recruited during their routine follow-up visit with their medical oncologist.
• Post - menopausal women with histologically confirmed hormonal positive (ER and/or PR) invasive breast cancer stages I - III with no evidence of metastatic disease (M0).
• Patients must be on one of AI (steroidal or non-steroidal).
• Patient must have completed local treatment (surgery /radiation) and recovered from all side effects of chemotherapy and surgery.
• Patient must be able to complete a demographic and the MMAS - 8 questionnaires in English or Spanish.

Enrollment: 152 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Post - menopausal women with histologically confirmed hormonal positive (ER and/or PR) invasive breast cancer stages I - III with no evidence of metastatic disease (M0).
• Patient must have completed local treatment (surgery /radiation) and recovered from all side effects of chemotherapy and surgery.
• Patient must be on one of AI (steroidal or non-steroidal).
• Patient must be able to complete a demographic and the MMAS - 8 questionnaires in English or Spanish

Exclusion criteria

• < 18 years old